CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ProVerum Limited is developing a minimally invasive implant called ProVee to treat Benign Prostatic Hyperplasia, a common condition affecting older men. The device aims to alleviate urinary symptoms through a quick outpatient procedure.
ProVerum Limited, an innovative Dublin based SME focused on the development of novel minimally invasive technologies to treat Benign Prostatic Hyperplasia, a common condition in older men causing difficulty with urination with a profound deterioration in quality of life.
The company’s first product (called ‘ProVee’) is a self-expanding implant that alleviates the symptoms caused by BPH.
Benign Prostatic Hyperplasia is an enlargement of the prostate gland which causes impingement upon the urethra…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
